Long-term Survival in Asymptomatic Patients with Severe Degenerative Mitral Regurgitation: a Propensity Score-based Comparison Between an Early Surgical Strategy and a Conservative Treatment Approach
Overview
Authors
Affiliations
Aims: The management of asymptomatic severe mitral regurgitation remains controversial. The aim of the study was to assess the long-term survival, incidence of cardiac complications, factors that predict outcome, and effect of mitral surgery on the long-term prognosis of patients with asymptomatic severe mitral regurgitation amenable to valve repair.
Methods: One hundred ninety-two asymptomatic patients (mean age, 63 +/- 13 years) with severe degenerative mitral regurgitation diagnosed by 2-dimensional echocardiography between 1990 and 2001 were prospectively followed for a median of 8.5 years.
Results: Overall, cardiovascular, and event-free survival was evaluated in 2 groups of patients: a "conservative approach" group (n = 67) and an "early surgery" group (n = 125). Outcomes were also analyzed among patients with atrial fibrillation, pulmonary hypertension, or both, as well as in patients free of any mitral regurgitation complications. In the whole population, 10-year overall survival was significantly lower with the conservative approach than early surgery (50% +/- 7% vs 86% +/- 4%, log-rank < 0.0001). Similar results were obtained in the subgroups with atrial fibrillation and/or pulmonary hypertension. The 10-year propensity-matched score-adjusted hazards ratio for overall mortality, cardiac mortality, and cardiovascular events for the conservative treatment were 5.21, 4.83, and 4.40, respectively.
Conclusion: Our results show that the outcome of asymptomatic patients with severe degenerative mitral regurgitation is better with an early surgical approach rather than a more conservative treatment strategy.
Pulmonary arterial compliance as a measure of right ventricular loading in mitral regurgitation.
Kempton H, Hungerford S, Muller D, Hayward C Int J Cardiol Heart Vasc. 2024; 53:101472.
PMID: 39171287 PMC: 11338128. DOI: 10.1016/j.ijcha.2024.101472.
Jain C, Miranda W, Connolly H, Madhavan M, Egbe A JACC Adv. 2024; 1(1):100007.
PMID: 38939082 PMC: 11198577. DOI: 10.1016/j.jacadv.2022.100007.
Tsampasian V, Militaru C, Parasuraman S, Loudon B, Lowery C, Rudd A Eur Heart J Cardiovasc Imaging. 2024; 25(8):1051-1058.
PMID: 38925103 PMC: 11288748. DOI: 10.1093/ehjci/jeae127.
Left ventricular ejection fraction: clinical, pathophysiological, and technical limitations.
Vancheri F, Longo G, Henein M Front Cardiovasc Med. 2024; 11:1340708.
PMID: 38385136 PMC: 10879419. DOI: 10.3389/fcvm.2024.1340708.
Mitral Valve Transcatheter Edge-to-Edge Repair Volumes and Trends.
Kumar K, Simpson T, Golwala H, Chhatriwalla A, Chadderdon S, Smith R J Interv Cardiol. 2023; 2023:6617035.
PMID: 38149109 PMC: 10751158. DOI: 10.1155/2023/6617035.